| GHGuardant Health Inc. | 3,338,241 | $308.4M |
| IMVTImmunovant, Inc. | 11,526,971 | $286.3M |
| TARSTarsus Pharmaceuticals, Inc. | 3,600,000 | $252.5M |
| PCVXVaxcyte, Inc. | 4,300,000 | $249.9M |
| GPCRStructure Therapeutics Inc. | 4,279,848 | $206.3M |
| AXSMAxsome Therapeutics, Inc. | 1,100,000 | $185.9M |
| APLSApellis Pharmaceuticals, Inc. | 4,532,374 | $182.3M |
| OCULOCULAR THERAPEUTIX, INC | 19,686,282 | $166.7M |
| VERAVera Therapeutics, Inc. | 4,106,067 | $165.2M |
| ALMSALUMIS INC. | 6,772,595 | $149.2M |
| IONSIONIS PHARMACEUTICALS INC | 1,950,000 | $146.4M |
| NUVLNuvalent, Inc. | 1,376,324 | $141.0M |
| ALKSAlkermes plc. | 3,590,323 | $127.0M |
| CNTACentessa Pharmaceuticals plc | 3,158,041 | $125.4M |
| MLTXMoonLake Immunotherapeutics | 6,408,863 | $119.5M |
| MAZEMaze Therapeutics, Inc. | 3,477,562 | $103.8M |
| ORKAOruka Therapeutics, Inc. | 2,034,203 | $99.8M |
| NRIXNurix Therapeutics, Inc. | 6,345,244 | $98.4M |
| GMABGenmab A/S | 3,663,250 | $98.3M |
| CYTKCYTOKINETICS INC | 1,374,320 | $90.6M |
| LBRXLB PHARMACEUTICALS INC | 3,352,804 | $82.7M |
| MBXMBX Biosciences, Inc. | 2,757,569 | $82.3M |
| BCAXBicara Therapeutics Inc. | 4,062,500 | $80.8M |
| CMPSCOMPASS Pathways plc | 12,161,496 | $67.3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 1,150,000 | $65.0M |
| BBIOBridgeBio Pharma, Inc. | 841,445 | $62.5M |
| IMCRImmunocore Holdings plc | 1,931,884 | $58.2M |
| TNGXTango Therapeutics, Inc. | 2,750,000 | $57.5M |
| DFTXDefinium Therapeutics Inc. | 3,000,000 | $56.7M |
| TERNTerns Pharmaceuticals, Inc. | 1,073,877 | $56.6M |
| GERNGERON CORP | 31,720,278 | $47.3M |
| ANIPANI PHARMACEUTICALS INC | 600,000 | $46.1M |
| CRMDCorMedix Inc. | 6,274,076 | $42.6M |
| ATAIAtai Beckley N.V. | 12,000,000 | $42.5M |
| CLDXCelldex Therapeutics, Inc. | 1,283,979 | $40.7M |
| COGTCogent Biosciences, Inc. | 1,000,000 | $38.5M |
| CRVSCorvus Pharmaceuticals, Inc. | 2,491,539 | $36.5M |
| DYNDyne Therapeutics, Inc. | 2,000,000 | $36.3M |
| SLNOSOLENO THERAPEUTICS INC | 1,078,710 | $36.1M |
| ACRSAclaris Therapeutics, Inc. | 9,345,000 | $35.0M |
| MANEVeradermics Incorporated | 500,000 | $31.6M |
| VSTMVerastem, Inc. | 5,740,850 | $30.4M |
| VRDNViridian Therapeutics, Inc.\DE | 1,393,944 | $27.3M |
| XFORX4 Pharmaceuticals, Inc | 6,339,535 | $26.2M |
| SLDBSolid Biosciences Inc. | 3,565,062 | $25.7M |
| ENTAENANTA PHARMACEUTICALS INC | 1,956,867 | $24.7M |
| APGEApogee Therapeutics, Inc. | 285,000 | $24.0M |
| KURAKura Oncology, Inc. | 2,643,542 | $21.5M |
| IPSCCentury Therapeutics, Inc. | 9,487,745 | $21.4M |
| BEAMBeam Therapeutics Inc. | 820,765 | $19.6M |
| CNTXContext Therapeutics Inc. | 7,419,355 | $19.4M |
| JANXJanux Therapeutics, Inc. | 1,187,290 | $16.5M |
| PMNProMIS Neurosciences Inc. | 835,655 | $10.6M |
| CBIOCRESCENT BIOPHARMA, INC. | 453,686 | $8.3M |
| IVAInventiva S.A. | 1,222,453 | $6.8M |
| LRMRLarimar Therapeutics, Inc. | 1,500,000 | $6.8M |
| HELPCYBIN INC. | 1,313,137 | $6.3M |
| ALGSAligos Therapeutics, Inc. | 444,110 | $3.3M |